Cancer Control Program (CC)

癌症控制程序 项目摘要/摘要 潮家综合癌症中心(CFCCC)癌症控制(CC)计划的科学目标 是促进和促进识别和降低癌症风险并改善癌症结果的研究，以及 患者和幸存者在CFCCC集水区及更远地区的生活质量。CC计划有助于 加强知识基础，以开发、实施、 评估并向我们的社区传播预防和降低癌症发病率、死亡率、 和发病率。CC成员与社区外联和参与办公室(COE)密切合作，并 在进行人群研究和临床试验方面提供领导和指导。CC会员玩游戏 在将发现转化为大众方面发挥着重要作用。CC计划的具体目标是确定、 了解和控制风险因素，通过诊断、治疗和治疗来预防癌症和改善预后 提高存活率的干预措施。CC成员进行跨越癌症控制连续体的研究。 研究人员检查基因组和环境对癌症的影响；设计、实施和评估 增加癌症筛查的临床试验；开发和评估提高生活质量的创新方法 在患有癌症的儿童、青少年和年轻人中，测试癌症幸存者的新生物行为干预措施； 进行临床试验以改善结果并防止复发；努力减少影响 那些生活在我们社区内外的人。 成员：来自19个部门和5所学校的45名成员 资金：1,528,757美元NCI(导演)；3,988,348美元其他同行评审(导演) 应计项目：干预：1,015；治疗：0；机构/调查人员发起：1,132 出版物：总数：607份；高影响力期刊：84份(14%)；方案内：68份(11%)； 方案间：92(15%)；机构间：410(68%)

CANCER CONTROL PROGRAM PROJECT SUMMARY/ABSTRACT The scientific goals of the Chao Family Comprehensive Cancer Center (CFCCC) Cancer Control (CC) Program are to foster and facilitate research that identifies and reduces cancer risk and improves cancer outcomes and quality of life for patients and survivors in the CFCCC Catchment Area and beyond. The CC Program contributes to the overall mission of the CFCCC by strengthening the knowledge base for developing, implementing, evaluating, and disseminating strategies to our community to prevent and reduce cancer incidence, mortality, and morbidity. CC members work closely with the Office of Community Outreach and Engagement (COE) and provide leadership and guidance in conducting population-based studies and clinical trials. CC members play an important role in translating discoveries to the population. The CC Program Specific Aims are to identify, understand, and control risk factors to prevent cancer and improve outcomes through diagnosis, treatment and interventions to improve survivorship. CC members conduct research that spans the cancer control continuum. Researchers examine genomic and environmental influences on cancer; design, implement, and evaluate clinical trials to increase cancer screening; develop and assess innovative approaches to improve quality of life in children, adolescents, and young adults with cancer; test novel biobehavioral interventions in cancer survivors; conduct clinical trials to improve outcomes and prevent recurrence; and work to reduce disparities that impact those living within our community and beyond. Membership: 45 Members from 19 Departments and 5 Schools Funding: $1,528,757 NCI (Directs); $3,988,348 Other Peer-Reviewed (Directs) Accruals: Interventional: 1,015; Treatment: 0; Institutional/Investigator-Initiated: 1,132 Publications: Total: 607; High Impact Journal: 84 (14%); Intra-programmatic: 68 (11%); Inter-programmatic: 92 (15%); Inter-Institutional: 410 (68%)